Type
1.
Kool, Moet, Vergunst. Lepra, onhandelbaar? Wat kan de betekenis van fysiotherapie zijn voor iemand met een door lepra aangetaste hand?. [Nieuwegein]: Hogeschool voor fysiotherapie "Tim van der Laan"; 2004. p. 82 p.
Type
1.
Namadi. Investigating factors affecting treatment regularity of leprosy patients detected during LEC and self-reporting : Analysis of a study in Jigawa State, Nigeria. [Amsterdam]: Royal Tropical Institute; 2002. p. 58 p.
Type
1.
Wang. Barriers of case finding and adherence to treatment of tuberculosis in rural area of Inner Mongolia, P.R. China. [Amsterdam]: Royal Tropical Institute; 2004. p. 34 p.
Type
1.
Koning. Are guidelines for field treatment of leprosy reactions evidence-based? A metanalysis. [Antwerp]: Prins Leopold Instituut voor Tropische Geneeskunde; 2008. p. 22 p.
Type
1.
Lange, Stam. Skintherapeutical interventions in the treatment of leprosy: A study at Tugurejo hospital in Semarang, Indonesia. [Utrecht]: Hogeschool Utrecht; 2007. p. 69 p.
Type
1.
Zeegelaar. Aspects of tropical ulcerating diseases. [s.l.]: Buijten & Schipperheijn; 2008. p. 114 p.
Type
1.
Croft. The epidemiology, risk factors and response to treatment by corticosteroids of acute nerve function impairment in leprosy. [Oxford]: Oriel College; 1999. p. 206 p.
Type
1.
Borrie. Zur Rifampicinbehandlung der lepromatoesen Lepra: Eine elektronenmikroskopische Untersuchung. [Bonn]: Richard Schwartzbold; 1976. p. 108 p.
Type
1.
Huikeshoven. Patient compliance with dapsone administration in leprosy: analytical and pharmaceutical aspects. [Amsterdam]: Universiteit van Amsterdam; 1980. p. 148 p.
Type
1.
Chalise. Factors contributing to defaulting of leprosy patients in Dhanusha district Nepal. [Tanzania]: CEDHA; 1999. p. 60 p.